n-3 polyunsaturated fatty acids reverse the development of polyps in Apc(Min/+) transgenic mice

Oncol Rep. 2016 Jan;35(1):504-10. doi: 10.3892/or.2015.4359. Epub 2015 Oct 29.

Abstract

Dietary n-3 polyunsaturated fatty acids (n-3 PUFAs) have been demonstrated to reduce tumor load in Apc(Min/+) mice, supporting a role for n-3 PUFAs in the inhibition of colon carcinogenesis and progression. The aim of the present study was to investigate whether a diet enriched with n-3 PUFAs, known already to have anti-neoplastic efficacy in Apc(Min/+) mice, would reverse the development of intestinal polyps. For this purpose, Apc(Min/+) mice were randomly divided into 3 groups of 5 animal each and fed as follows: control ST1 and ST2 groups, received a purified AIN-93M standard diet for 5 and 10 weeks, respectively; the OM-3R group received a purified AIN-93M standard diet for 5 weeks and a diet supplemented with salmon oil, rich in n-3 PUFAs, for another 5 weeks. After dietary treatment, in intestinal tissue, we evaluated the polyp number and volume, expression levels of cell proliferation- and apoptosis-related proteins, as well as the protein expression of LDL receptor and the levels of fatty acid synthase (FAS) activity. The results showed the ability of a diet enriched with n-3 PUFAs to suppress intestinal polyps in Apc(Min/+) mice, and to significantly reverse polyp development associated with the downregulation of cell proliferation markers and with the induction of estrogen receptor β and LDL receptor, which are negative modulators of cellular proliferation. This noteworthy finding is important for a translational study evaluating the therapeutic role of n-3 PUFAs in the prevention and treatment of subjects with gastrointestinal diseases.

MeSH terms

  • Adenomatous Polyposis Coli Protein / genetics*
  • Animals
  • Cell Proliferation / drug effects
  • Colonic Polyps / diet therapy*
  • Colonic Polyps / genetics
  • Colonic Polyps / metabolism
  • Colonic Polyps / pathology*
  • Estrogen Receptor beta / metabolism
  • Fatty Acids, Omega-3 / administration & dosage*
  • Fatty Acids, Omega-3 / pharmacology
  • Gene Expression Regulation / drug effects
  • Male
  • Mice
  • Mice, Transgenic
  • Receptors, LDL / metabolism
  • Treatment Outcome

Substances

  • Adenomatous Polyposis Coli Protein
  • Estrogen Receptor beta
  • Fatty Acids, Omega-3
  • Receptors, LDL